日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The effect of antacid and mineral supplements on bictegravir pharmacokinetics: results from a Phase 1, open-label, drug-drug interaction study

抗酸剂和矿物质补充剂对比克替拉韦药代动力学的影响：一项 1 期开放标签药物相互作用研究的结果

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00781-25
Arora, Priyanka; Hindman, Jason T; West, Steve; Ling, John; Palaparthy, Ramesh; Marathe, Dhananjay D
发表日期：2026
文献求助 收藏

Getting c-literate: Bulboclitoris functional anatomy and its implications for radiotherapy

了解C语言：球状阴蒂的功能解剖及其对放射治疗的影响

期刊:Practical Radiation Oncology
影响因子:3.5
doi:10.1016/j.prro.2025.11.013
Greenwald, Lucy M; Williams, Andre; Downes, Margaret H; Reidenberg, Joy S; Collins, Victoria; Bane, Octavia; Bowen, Shaniel; Okorom, Amarachi; Dickstein, Daniel R; Garcia-Barros, Monica; Brody, Rachel; Hannan, Johanna L; Thor, Maria; Lymberis, Stella; Hindman, Nicole; Chubak, Barbara; Marshall, Deborah C
发表日期：2026
文献求助 收藏

Self-Determination Theory as a Framework for Research and Design of Digital Applications for Nurses' Well-Being

以自我决定理论为框架，研究和设计提升护士福祉的数字应用

期刊:
影响因子:
doi:10.1111/jan.16895
Hindman, James; Zugai, Joel; Foster, Kim; Raeburn, Toby
发表日期：2026
文献求助 收藏

Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

病毒血症事件后比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺（B/F/TAF）的疗效：HIV感染者研究的汇总分析

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01153-y
Pozniak, Anton; Orkin, Chloe; Yazdanpanah, Yazdan; Baumgarten, Axel; Mounzer, Karam; D'Antoni, Michelle L; Huang, Hailin; Liu, Hui; Andreatta, Kristen; VanderVeen, Laurie A; Callebaut, Christian; Hindman, Jason T; Arribas, José R
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus dolutegravir-based three-drug regimens in people with HIV with varying adherence to antiretroviral therapy

在不同抗逆转录病毒治疗依从性的HIV感染者中，比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺三药方案与基于多替拉韦的三药方案的疗效比较

期刊:Journal of Antimicrobial Chemotherapy
影响因子:3.6
doi:10.1093/jac/dkae407
Andreatta, Kristen; Sax, Paul E; Wohl, David; D'Antoni, Michelle L; Liu, Hui; Hindman, Jason T; Callebaut, Christian
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Bictegravir/emtricitabine/tenofovir alafenamide in adults with HIV-1 and end-stage kidney disease on chronic haemodialysis

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺用于接受慢性血液透析的HIV-1合并终末期肾病成人患者

期刊:Hiv Medicine
影响因子:3.2
doi:10.1111/hiv.13721
Eron, Joseph J; Ramgopal, Moti; Osiyemi, Olayemi; Mckellar, Mehri; Slim, Jihad; DeJesus, Edwin; Arora, Priyanka; Blair, Christiana; Hindman, Jason T; Wilkin, Aimee
HIV
微生物学
发表日期：2025
文献求助 收藏

Cervical myelopathy symptom severity, posterior-based cervical surgical approach, and lower body mass index are associated with postoperative delirium: A retrospective observational study

颈椎病症状严重程度、后路颈椎手术入路和较低的体重指数与术后谵妄相关：一项回顾性观察研究

期刊:North American Spine Society Journal
影响因子:2.5
doi:10.1016/j.xnsj.2025.100789
Olinger, Catherine R; Chen, Pei-Fu; Lee, Sarah J; Waldschmidt, Daniel F; Grieser-Yoder, Reagan A; Havertape, Lauren G; O'Connell-Moore, Debra J; Nguyen, Lanchi B; Corlette, Jill D; Hindman, Bradley J; Howard, Matthew A 3rd
发表日期：2025
文献求助 收藏

Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study

从多替拉韦/阿巴卡韦/拉米夫定方案转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺方案的疗效和安全性：一项3期随机、双盲、多中心、活性对照、非劣效性研究的开放标签扩展结果

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000041482
Brar, Indira; Ruane, Peter J; Berhe, Mezgebe; Brinson, Cynthia; Benson, Paul; Henry, Keith; Liu, Hui; Andreatta, Kristen; Hindman, Jason T; Ramgopal, Moti
发表日期：2025
文献求助 收藏

Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV

HIV 患者长期使用含比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺或多替拉韦的方案治疗后，其代谢变化情况如何？

期刊:Aids Research and Therapy
影响因子:
doi:10.1186/s12981-025-00732-w
Daar, Eric S; Orkin, Chloe; Sax, Paul E; Hagins, Debbie; Pozniak, Anton; Workowski, Kimberly; Brinson, Cynthia; Tiraboschi, Juan Manuel; Liu, Hui; Deaton, Chris; Cohen, Cal; Madera, Sharline; Hindman, Jason T; Ramgopal, Moti
HIV
代谢
微生物学
发表日期：2025
文献求助 收藏

Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies

比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺在接受一线治疗的黑人和西班牙裔/拉丁裔 HIV-1 感染成人中的疗效和安全性：两项 III 期研究的 5 年随访结果

期刊:Hiv Medicine
影响因子:
doi:10.1111/hiv.70018
Martorell, C; Ramgopal, M; Hagins, D; Osiyemi, O; Arribas, J R; Berhe, M; Yazdanpanah, Y; Orkin, C; Santiago, L; Rosero, C; Unger, N; Liu, H; Rogers, R; Hindman, J T; Wurapa, A
HIV
炎症/感染
微生物学
发表日期：2025
文献求助 收藏